Cargando…
A Matrix Metalloproteinase-2-Based Nomogram to Assess the Risk of Encapsulating Peritoneal Sclerosis in Peritoneal Dialysis Patients
BACKGROUND: Encapsulating peritoneal sclerosis (EPS) is a rare but serious complication of peritoneal dialysis (PD). So far, there is no biomarker-based prediction tool available for EPS. Matrix metalloproteinase-2 (MMP-2) is a protein involved in the breakdown of the extracellular matrix, and the e...
Autores principales: | Chou, Che-Yi, Tseng, Chin-Chung, Chen, Jin-Bor, Hung, Chin-Chuan, Huang, Chiu-Ching |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837760/ https://www.ncbi.nlm.nih.gov/pubmed/33532492 http://dx.doi.org/10.1155/2021/6666441 |
Ejemplares similares
-
Encapsulating Peritoneal Sclerosis in Long-Termed Peritoneal Dialysis Patients
por: Hsu, Heng-Jung, et al.
Publicado: (2018) -
Incidence and outcomes of encapsulating peritoneal sclerosis (EPS) and factors associated with severe EPS
por: Tseng, Chin-Chung, et al.
Publicado: (2018) -
Long-term peritoneal dialysis and encapsulating peritoneal sclerosis in children
por: Honda, Masataka, et al.
Publicado: (2010) -
Encapsulating peritoneal sclerosis as a late complication of peritoneal dialysis
por: Oran, Ebru, et al.
Publicado: (2015) -
Encapsulating Peritoneal Sclerosis after Long-term Peritoneal Dialysis Treatment
por: Tanitame, Keizo
Publicado: (2020)